SA520411478B1 - تركيبة لاستكمال الكالسيوم - Google Patents

تركيبة لاستكمال الكالسيوم

Info

Publication number
SA520411478B1
SA520411478B1 SA520411478A SA520411478A SA520411478B1 SA 520411478 B1 SA520411478 B1 SA 520411478B1 SA 520411478 A SA520411478 A SA 520411478A SA 520411478 A SA520411478 A SA 520411478A SA 520411478 B1 SA520411478 B1 SA 520411478B1
Authority
SA
Saudi Arabia
Prior art keywords
composition
calcium supplementation
supplementation
calcium
formulation
Prior art date
Application number
SA520411478A
Other languages
English (en)
Inventor
زاناتا صامويل
نيجياني فابيو
ديني لاورا
Original Assignee
ابيوجن فارما اس. بي. ايه
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ابيوجن فارما اس. بي. ايه filed Critical ابيوجن فارما اس. بي. ايه
Publication of SA520411478B1 publication Critical patent/SA520411478B1/ar

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30—Artificial sweetening agents
    • A23L27/33—Artificial sweetening agents containing sugars or derivatives
    • A23L27/37—Halogenated sugars
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A23L29/035—Organic compounds containing oxygen as heteroatom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
    • A23L29/27—Xanthan not combined with other microbial gums
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
    • B65D75/40—Packages formed by enclosing successive articles, or increments of material, in webs, e.g. folded or tubular webs, or by subdividing tubes filled with liquid, semi-liquid, or plastic materials
    • B65D75/44—Individual packages cut from webs or tubes
    • B65D75/48—Individual packages cut from webs or tubes containing liquids, semiliquids, or pastes, e.g. cushion-shaped packages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/306—Foods, ingredients or supplements having a functional effect on health having an effect on bone mass, e.g. osteoporosis prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/02—Acid
    • A23V2250/042—Lactic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/1578—Calcium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/50—Polysaccharides, gums
    • A23V2250/502—Gums
    • A23V2250/5086—Xanthan

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Mycology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pediatric Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mechanical Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

يتعلق الاختراع الحالي بصيغة في صورة معلق مائي aqueous suspension يشتمل على سيترات الكالسيوم calcium citrate . وتُظهر الصيغة المذكورة ثباتاً وامتثالاً ممتازين وتجد لها استخداماً في استكمال الكالسيوم calcium لدى الأشخاص المحتاجين لمثل هذا الاستكمال.
SA520411478A 2017-09-06 2020-03-05 تركيبة لاستكمال الكالسيوم SA520411478B1 (ar)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000099690A IT201700099690A1 (it) 2017-09-06 2017-09-06 Composizione per l’integrazione di calcio

Publications (1)

Publication Number Publication Date
SA520411478B1 true SA520411478B1 (ar) 2022-08-04

Family

ID=60991327

Family Applications (1)

Application Number Title Priority Date Filing Date
SA520411478A SA520411478B1 (ar) 2017-09-06 2020-03-05 تركيبة لاستكمال الكالسيوم

Country Status (23)

Country Link
US (1) US11058138B2 (ar)
EP (1) EP3678497B1 (ar)
JP (1) JP7308186B2 (ar)
KR (1) KR20200083971A (ar)
CN (1) CN111511222B (ar)
AU (1) AU2018327614B2 (ar)
BR (1) BR112020004453B1 (ar)
CA (1) CA3074893A1 (ar)
CY (1) CY1124633T1 (ar)
DK (1) DK3678497T3 (ar)
EA (1) EA202090654A1 (ar)
ES (1) ES2894115T3 (ar)
HR (1) HRP20211530T1 (ar)
HU (1) HUE056883T2 (ar)
IL (1) IL273032B (ar)
IT (1) IT201700099690A1 (ar)
LT (1) LT3678497T (ar)
MX (1) MX2020002545A (ar)
PL (1) PL3678497T3 (ar)
PT (1) PT3678497T (ar)
SA (1) SA520411478B1 (ar)
SI (1) SI3678497T1 (ar)
WO (1) WO2019048532A1 (ar)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851221A (en) * 1985-02-19 1989-07-25 Mission Pharmacal Company Liquid calcium supplementation from readily soluble mixtures of calcium compound and citric acid
US5075499A (en) * 1988-11-21 1991-12-24 Board Of Regents, The University Of Texas System Calcium supplementation by dicalcium citrate-lactate
US5232709A (en) * 1990-08-06 1993-08-03 The Procter & Gamble Company Calcium and trace mineral supplements comprising estrogen
AU677432B2 (en) * 1993-09-09 1997-04-24 Gerhard Gergely Effervescent granulated material and method for its preparation
CA2217264A1 (en) * 1995-04-07 1996-10-10 Abbott Laboratories Calcium supplements and calcium containing beverages comprising vitamin d
US5597595A (en) * 1995-04-07 1997-01-28 Abbott Laboratories Low pH beverage fortified with calcium and vitamin D
US5817351A (en) * 1995-04-07 1998-10-06 Abbott Laboratories Calcium fortified low pH beverage
EP3138566B1 (en) * 2003-11-17 2022-01-26 BioMarin Pharmaceutical Inc. Treatment of phenylketonuria with bh4
CN1901817A (zh) * 2003-12-04 2007-01-24 普拉克生化公司 含有乳酸葡糖酸柠檬酸钙的淡口感钙强化饮料
US7267832B2 (en) * 2004-02-18 2007-09-11 Kraft Foods Holdings, Inc. Amorphous water-soluble calcium citrate salts and method of making and using same
US20070065542A1 (en) * 2005-09-20 2007-03-22 Board Of Regents, The University Of Texas System Enhanced solubility of preformed calcium citrate by adding citric acid
US7968130B2 (en) * 2006-01-11 2011-06-28 Mission Pharmacal Co. Calcium-enriched food product
EP1993386A4 (en) * 2006-02-21 2010-05-26 Nutrijoy Inc COMPOSITION AND PROCESS FOR THE PREPARATION OF FOOD PRODUCTS AND BEVERAGES HAVING IMPROVED TASTE PRINTING CONTAINING PROTEIN AND FRUIT JUICES ENRICHED NUTRITIONALLY BY CALCIUM AND OLIGO-ELEMENTS
EP2198889A1 (en) * 2008-12-22 2010-06-23 Almirall, S.A. Liquid pharmaceutical compositions comprising a triptan compound and Xylitol
CN101904350B (zh) * 2010-07-23 2013-09-25 内蒙古伊利实业集团股份有限公司 一种强化钙含量的发酵乳饮料及其生产方法
EP2462922A1 (en) * 2010-12-10 2012-06-13 Bioprojet New form of administration of enkephalinase inhibitor
JP2014512189A (ja) * 2011-04-20 2014-05-22 スターリング・インターナショナル・インコーポレイテッド セミオケミカルの制御放出のための方法およびディスペンサ
EP2920180A4 (en) * 2012-11-15 2016-04-13 Pharmacyclics Inc PYRROLOPYRIMIDINE COMPOUNDS AS KINASE INHIBITORS
JP2022531129A (ja) * 2019-04-23 2022-07-06 テトラ ディスカバリー パートナーズ インコーポレイテッド Ｐｄｅ４ｄ阻害剤としての３－ヒドロキシ－２－フェニル－６－（ピラゾール－４－イルメチル）ピリジン誘導体

Also Published As

Publication number Publication date
WO2019048532A1 (en) 2019-03-14
EA202090654A1 (ru) 2020-06-24
KR20200083971A (ko) 2020-07-09
DK3678497T3 (da) 2021-09-20
LT3678497T (lt) 2021-12-27
BR112020004453A2 (pt) 2020-09-15
HUE056883T2 (hu) 2022-03-28
PL3678497T3 (pl) 2022-01-31
JP2020532569A (ja) 2020-11-12
CY1124633T1 (el) 2022-07-22
MX2020002545A (es) 2020-10-01
AU2018327614A1 (en) 2020-03-19
SI3678497T1 (sl) 2022-01-31
IL273032B (en) 2022-01-01
ES2894115T3 (es) 2022-02-11
CN111511222B (zh) 2023-05-30
US11058138B2 (en) 2021-07-13
IL273032A (en) 2020-04-30
IT201700099690A1 (it) 2019-03-06
PT3678497T (pt) 2021-10-04
CN111511222A (zh) 2020-08-07
BR112020004453B1 (pt) 2023-11-14
CA3074893A1 (en) 2019-03-14
EP3678497A1 (en) 2020-07-15
US20200375238A1 (en) 2020-12-03
AU2018327614B2 (en) 2024-05-16
HRP20211530T1 (hr) 2021-12-24
EP3678497B1 (en) 2021-07-21
JP7308186B2 (ja) 2023-07-13

Similar Documents

Publication Publication Date Title
PL3668937T3 (pl) Kompozycje i zastosowania Z-1-chloro-2,3,3,3-tetrafluoroprop-1-enu
MX2023011657A (es) Composiciones que comprenden curones y usos de los mismos.
WO2015120138A3 (en) AGENTS THAT MODULATE RGMb-NEOGENIN-BMP SIGNALING AND METHODS OF USE THEREOF
EP4218736A3 (en) Compositions comprising 15-hepe
MX2020001885A (es) Formulaciones de daptomicina.
MX2020006596A (es) Hidroxiisoxazolinas y derivados de estos.
IL281938A (en) Stable compositions of semaglutide and uses thereof
MX2019005855A (es) Formulaciones que se pueden pulverizar.
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
TR201713929A2 (tr) Ki̇tosan ve alji̇natin hemostati̇k kompozi̇syonlari
MX2017016096A (es) Agente antihipertensivo.
IN2014CH00840A (ar)
MY193776A (en) Modified cytotoxins and their therapeutics use
GEP20237486B (en) Formulations of copanlisib
MX2019011613A (es) Formulaciones de acido 1-amino-1-ciclopropanocarboxilico.
MX2016016613A (es) Composicion en forma de particulas compactadas y su uso.
PH12016502386A1 (en) Oral care compositions
EA201691792A1 (ru) Фармацевтические составы на основе вилдаглиптина
MX2017013278A (es) Odorante osmanthus.
MY181719A (en) Fragrance and flavor compositions comprising neopentyl glycol diacetate
MX2019010218A (es) Derivados de pirazol como inhibidores de bromodominio.
MX2021004115A (es) Derivados de alcoxibenzaldehido y precursores de los mismos.
SA520411478B1 (ar) تركيبة لاستكمال الكالسيوم
GEP20196957B (en) Crystalline forms of s-acetyl glutathione, their reparations and uses in pharmaceutical and nutraceutical formulations
MX2021001361A (es) Composicion liquida de fibrinogeno humano.